Australian clinical feasibility considerations for treatment of PTSD with cannabinoid-augmented exposure therapy

Aust N Z J Psychiatry. 2024 Mar;58(3):198-200. doi: 10.1177/00048674231216587. Epub 2023 Dec 7.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Australia
  • Cannabinoids* / therapeutic use
  • Feasibility Studies
  • Humans
  • Implosive Therapy*
  • Stress Disorders, Post-Traumatic* / drug therapy
  • Treatment Outcome

Substances

  • Cannabinoids